The Ozempic effect: From shopping baskets to dips in Danish GDP
As GLP-1 use spreads, grocers and restaurants see lighter baskets, airlines predict fuel savings and health systems eye lower costs—while Denmark sees a clipped GDP.
How Novo Nordisk failed to protect its GLP-1 patent
Traditional intellectual property tools have proved insufficient against pharmacy compounders producing weight-loss drugs
NVO’s Wegovy vs. LLY’s Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk NVO announced data from a head-to-head study evaluating the risk of major adverse cardiovascular events with Wegovy compared with Eli Lilly’s LLY tirzepatide in patients with overweight or obesity and established cardiovascular disease (CVD) without diabetes. The results from this STEER real-world study, which gathered evidence from actual patient experiences, were recently presented at a medical […]
Expect health insurance prices to rise next year, brokers and experts say
Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year. Health insurance will grow more expensive in many corners of the market in 2026, and coverage may shrink. That could leave patients paying more for doctor visits and dealing with prescription coverage changes. Price increases […]
Expect health insurance prices to rise next year, brokers and experts say
Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year. Health insurance will grow more expensive in many corners of the market in 2026, and coverage may shrink. That could leave patients paying more for doctor visits and dealing with prescription coverage changes. Price increases […]
Comment on: “Relative Effectiveness and Safety of the GLP-1 Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics” [Letter]
Join the millions who’ve lost stubborn weight using the same active ingredient as Ozempic – but cheaper and WITHOUT insurance
SHOPPING: Take control of your weight loss journey with the program that makes GLP-1 injections accessible – for a reasonable price without the need for insurance, and with plenty of support.
Chef-powered meal service CookUnity launches food is medicine initiative with EmblemHealth
For doctors and patients alike, healing chronic conditions with food requires access to several months’ worth of medically tailored meals. “If you send them meals that are frozen, don’t taste good, or are not culturally relevant, you’re not going to get the outcome you want,” says Bruno Didier, head of B2B at the chef-made meal […]
Semaglutide targets MASH molecular pathways beyond weight loss
Nature Medicine, Published online: 01 September 2025; doi:10.1038/s41591-025-03927-w A proteomic study begins to identify the direct and indirect effects of GLP-1 treatment on metabolic dysfunction-associated steatohepatitis (MASH), and reveals insights into treatment-induced changes in liver histology.
Surgeon weighs in on bariatric surgery vs weight loss drugs to beat obesity: Do GLP-1 drugs work better?
Bariatric surgery and GLP-1 medications are significant treatment methods for obesity, but require ongoing lifestyle management and have likely side effects.